Voyager Therapeutics, Inc.
MX ˙ BMV ˙ US92915B1061
SecurityMX:VYGR / Voyager Therapeutics, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership875,568 shares
Latest Disclosed Value $ 3,379,735
Dimensional Fund Advisors Lp reports 19.27% decrease in ownership of VYGR / Voyager Therapeutics, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 875,568 shares of Voyager Therapeutics, Inc. (MX:VYGR) valued at $3,379,735 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,084,499 shares of Voyager Therapeutics, Inc.. This represents a change in shares of -19.27% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 875,568 -208,931 -19.27 3,380 -20.72 0.0002
2026-02-12 2025-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 1,084,499 -198,657 -15.48 4,262 -28.87 0.0009
2025-11-12 2025-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 1,283,156 -138,026 -9.71 5,993 35.60 0.0013
2025-08-12 2025-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 1,421,182 -75,102 -5.02 4,419 -12.63 0.0010
2025-05-13 2025-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 1,496,284 115,669 8.38 5,059 -35.38 0.0013
2025-02-13 2024-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 1,380,615 275,571 24.94 7,828 21.09 0.0019
2024-11-07 2024-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 1,105,044 291,364 35.81 6,465 0.45 0.0016
2024-08-09 2024-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 813,680 -291,875 -26.40 6,436 -37.48 0.0017
2024-05-10 2024-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 1,105,555 173,324 18.59 10,293 30.81 0.0028
2024-02-07 2023-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 932,231 153,291 19.68 7,869 30.35 0.0023
2023-11-09 2023-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 778,940 445,545 133.64 6,037 58.13 0.0020
2023-08-09 2023-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 333,395 103,548 45.05 3,817 115.41 0.0012
2023-05-12 2023-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 229,847 89,036 63.23 1,772 0.0006
2023-02-09 2022-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 140,811 46,788 49.76 1 -100.00 0.0003
2022-11-10 2022-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 94,023 -16,403 -14.85 556 -14.72 0.0002
2022-08-12 2022-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 110,426 79,166 253.25 652 173.95 0.0002
2022-05-13 2022-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 31,260 0 0.00 238 180.00 0.0001
2022-02-09 2021-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 31,260 -14,765 -32.08 85 -29.75 0.0000
2021-11-12 2021-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 46,025 -6,295 -12.03 121 -43.98 0.0000
2021-08-12 2021-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 52,320 -8,541 -14.03 216 -24.74 0.0001
2021-05-14 2021-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 60,861 12,949 27.03 287 -16.33 0.0001
2021-03-08 2020-12-31 13F/A-2 VOYAGER THERAPEUTICS COM 92915B106 47,912 1,741 3.77 343 -30.43 0.0001
2021-02-11 2020-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 47,912 1,741 343 123.8734
2020-11-12 2020-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 46,171 0 0.00 493 -15.44 0.0002
2020-08-13 2020-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 46,171 2,520 5.77 583 46.12 0.0003
2020-05-14 2020-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 43,651 30,378 228.87 399 115.68 0.0002
2020-02-14 2019-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 13,273 13,273 185 0.0001
2019-08-12 2019-03-31 13F/A-2 VOYAGER THERAPEUTICS COM 92915B106 0 -13,786 -100.00 0 -100.00
2019-02-26 2018-12-31 13F/A-1 VOYAGER THERAPEUTICS COM 92915B106 13,786 -5,623 -28.97 130 -64.58 0.0001
2019-02-13 2018-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 13,786 -5,623 130
2018-11-13 2018-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 19,409 -20,484 -51.35 367 -52.95 0.0001
2018-08-10 2018-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 39,893 -41,553 -51.02 780 -49.02 0.0003
2018-05-11 2018-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 81,446 -23,526 -22.41 1,530 -12.22 0.0006
2018-02-12 2017-12-31 13F VOYAGER THERAPEUTICS COM 92915B106 104,972 -942 -0.89 1,743 -20.08 0.0007
2017-11-13 2017-09-30 13F VOYAGER THERAPEUTICS COM 92915B106 105,914 7,786 7.93 2,181 148.12 0.0010
2017-08-11 2017-06-30 13F VOYAGER THERAPEUTICS COM 92915B106 98,128 68,574 232.03 879 124.81 0.0004
2017-05-12 2017-03-31 13F VOYAGER THERAPEUTICS COM 92915B106 29,554 29,554 391 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.